These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31663198)

  • 1. Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management.
    Huo D; Jiang X; Hu Y
    Adv Mater; 2020 Jul; 32(27):e1904337. PubMed ID: 31663198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges.
    Lin G; Zhou J; Cheng H; Liu G
    Small; 2023 Jul; 19(28):e2207973. PubMed ID: 36971279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine solutions to intricate physiological-pathological barriers and molecular mechanisms of tumor multidrug resistance.
    Li Y; Xu X
    J Control Release; 2020 Jul; 323():483-501. PubMed ID: 32387548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines.
    Qin SY; Zhang AQ; Zhang XZ
    Small; 2018 Nov; 14(45):e1802417. PubMed ID: 30247806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles with transformable physicochemical properties for overcoming biological barriers.
    Lu Q; Yu H; Zhao T; Zhu G; Li X
    Nanoscale; 2023 Aug; 15(32):13202-13223. PubMed ID: 37526946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals.
    López-Estévez AM; Lapuhs P; Pineiro-Alonso L; Alonso MJ
    Adv Mater; 2024 Apr; 36(14):e2309355. PubMed ID: 38104275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.
    Wang J; Zhou M; Chen F; Liu X; Gao J; Wang W; Wang H; Yu H
    J Biomed Nanotechnol; 2021 Aug; 17(8):1486-1509. PubMed ID: 34544528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
    Shen S; Liu M; Li T; Lin S; Mo R
    Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques.
    Pegoraro C; Domingo-Ortí I; Conejos-Sánchez I; Vicent MJ
    Adv Drug Deliv Rev; 2024 Apr; 207():115195. PubMed ID: 38325562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to improve tumor penetration of nanomedicines through nanoparticle design.
    Zhang YR; Lin R; Li HJ; He WL; Du JZ; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1519. PubMed ID: 29659166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brave new world revisited: Focus on nanomedicine.
    Fadeel B; Alexiou C
    Biochem Biophys Res Commun; 2020 Nov; 533(1):36-49. PubMed ID: 32921412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming multidrug resistance with nanomedicines.
    Ganoth A; Merimi KC; Peer D
    Expert Opin Drug Deliv; 2015 Feb; 12(2):223-38. PubMed ID: 25224685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.